$HTGM John’s Hopkins scheduled to vouch for the tech tomorrow AM. Says just about everything you need to know. Oncological Diagnostics is the sector these molecular companies are battling for. JH remains among the key opinion leader in healthcare as far as I’m concerned. Should be good.